Pituitary

Papers
(The TQCC of Pituitary is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A Pituitary Society update to acromegaly management guidelines155
COVID-19 and the pituitary65
Postoperative diabetes insipidus: how to define and grade this complication?51
Pituitary apoplexy associated with acute COVID-19 infection and pregnancy48
Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective47
Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis44
Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review41
The 5-factor modified frailty index predicts health burden following surgery for pituitary adenomas38
Descriptive epidemiology of craniopharyngiomas in the United States36
Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review35
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly26
Feasibility of machine learning based predictive modelling of postoperative hyponatremia after pituitary surgery26
Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomas26
Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review25
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection24
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement24
Trends in endoscopic and microscopic transsphenoidal surgery: a survey of the international society of pituitary surgeons between 2010 and 202023
Mice with gene alterations in the GH and IGF family22
Pre-operative serum inflammation-based scores in patients with pituitary adenomas21
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score21
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study21
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome20
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome18
Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma18
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States17
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI16
Opioids and pituitary function: expert opinion16
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study16
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis16
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study16
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study15
Ectopic pituitary adenomas: clinical features, diagnostic challenges and management15
Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas15
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice15
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression14
Virtual magnetic resonance elastography has the feasibility to evaluate preoperative pituitary adenoma consistency14
Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study14
Pituitary adenomas in older adults (≥ 65 years): 90-day outcomes and readmissions: a 10-year endoscopic endonasal surgical experience14
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas14
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis14
Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age14
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation14
Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease14
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples13
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile13
Targeted therapies in the medical management of craniopharyngioma12
The NETting of pituitary adenoma: a gland illusion12
Normative data for pituitary size and volume in the general population between 50 and 66 years12
Cushing’s disease: adrenal steroidogenesis inhibitors12
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications12
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly12
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system12
Glucocorticoid receptor blockers12
AIP variant causing familial prolactinoma12
Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification12
Metabolic syndrome and its components in adult hypopituitary patients12
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)12
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients12
The sellar barrier on preoperative imaging predicts intraoperative cerebrospinal fluid leak: a prospective multicenter cohort study12
ACTH increment post total bilateral adrenalectomy for Cushing’s disease: a consistent biosignature for predicting Nelson’s syndrome11
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma11
Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST)11
Modern imaging in Cushing’s disease11
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience11
Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery11
Quality of life impairment after a diagnosis of Cushing’s syndrome11
Cardiovascular health and mortality in Cushing’s disease10
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results10
Prolactin immunoassay: does the high-dose hook effect still exist?10
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis10
Typing of inflammatory lesions of the pituitary10
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers10
HOMA-IR in acromegaly: a systematic review and meta-analysis10
The importance of specialized sleep investigations in children with a suprasellar tumor10
Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study10
Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis10
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery10
Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis10
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)9
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis9
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)9
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients9
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy9
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis9
Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas9
High accuracy of bilateral and simultaneous petrosal sinus sampling with desmopressin for the differential diagnosis of pediatric ACTH-dependent Cushing’s syndrome9
0.044470071792603